Uncategorized

A machine-learning model identifies M3-like subtype in AML based on PML/RARα targets



The typical genomic feature of acute myeloid leukemia (AML) M3 subtype is the fusion event of PML/RARα, and ATRA/ATO-based combination therapy is current standard treatment regimen for M3 subtype.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *